Topic Archives: Breast Cancer

This particular bit of news leaves your friend Doc Gumshoe shaking his head in puzzlement.  To wit, in the US it is expected that there will be a substantial shortage of physicians in the upcoming years.   The American Association of Medical Colleges predicts that this shortage may reach about 122,000 physicians by the year […]

The only reason I accepted his invitation to circle the dance floor is that his latest foray into temptation has to do with pluripotent stem cells, a highly interesting, extremely complex, and promising area of serious scientific investigation. But before I attempt to follow Dr Sears’ complicated dance routine, there’s another bit of news that […]

[ed. note: Michael Jorrin, who I call Doc Gumshoe, is a longtime medical writer (not a doctor) who writes for us about medicine and health a couple times a month. He has agreed to our trading and disclosure restrictions, but does not generally write directly about investment ideas. His ideas, thoughts and words are his […]

[Ed note: Following is another installment from our favorite medical scribe, “Doc Gumshoe” (no, he’s not a doctor). We feature Michael’s commentary every couple weeks or so, and his thoughts and words are his own. “Doc” doesn’t pick stocks, but FDA decisions are a huge driver of investment success for pharmaceutical and biotech companies and […]

[ed note: We feature the musings of our favorite health and medicine writer, Michael Jorrin, a couple times a month, and we’ve taken the liberty of calling him “Doc Gumshoe” (he’s not a doctor). You’ll find no stock picks in his pieces, but hopefully will get plenty of insight into the medical matters he explains […]

Comments

  • Avatar

    Biotech is one of PM's specialties when he was managing hedge funds. PM is bullish on GILD as it has a blockbuster bre...

  • Avatar

    I did not see how to post this to Doc other than by commenting here; sorry. This link describes good preliminary resu...

  • Avatar

    Travis, Any thoughts on CYDY (Cytodyn) and their PH3 trials for a Covid therapeutic? Also in the pipeline for HIV, Brea...

  • Avatar

    The physicians on the "expert" panel are a bunch of breast cancer doctors with no real research knowledge of cannabis an...

  • Avatar

    Leronlimab by Cytodyn has my vote. In eliminating the cytosine storm, the cause of Covid deaths, it will likely be the c...

  • Avatar

    Travis Johnson from this quote, “This Breast Cancer Drug Will Spark a Big Pharma Bidding War” . Do you think it coul...

  • Avatar

    20 years of Mamogram radiation causes breast cancer. the false positives leading to unecessary "treatment" are even wors...

  • Avatar

    Mike......interesting. I, too, am a recent member of Black Optics; actually, his Nucleus program. So, today, first tra...

  • Avatar

    Joinhttps://www.cytodyn.com/media/press-releases/detail/296/cytodyn-files-ind-and-protocol-for-phase-1b2-clinical the di...

  • Avatar

    Outstanding review. Another interesting potential therapy involves the CCR5 receptor on T-cells. This receptor function...

  • Avatar

    SAN DIEGO, Oct. 22, 2018 /PRNewswire/ -- Halozyme Therapeutics, Inc. (NASDAQ: HALO) today announced the presentation of ...

  • Avatar

    CytoDyn Announces Plan to Develop PRO 140 for Metastatic Triple-Negative Breast Cancer as Initial Oncology Indication. h...

  • Avatar

    My Daughter fought and lost her battle with Breast Cancer and the Braca-2 gene! She was diagnosed as triple negative.. ...

  • Avatar

    InMed CEO Eric Adams reveals info about their work with breast cancer on an interview with James West / MidasLetter, Apr...

  • Avatar

    I don't see this as Hyasynth as they are a private complamy not traded. All the clues leed to InMed Pharma. A look at so...

  • Avatar

    Appears to be INMED. My only concern is their website and last press release in May 2018 doesn't mention anything about ...

  • Avatar

    https://www.angelnexus.com/o/web/165728 Hello, did anyone notice that the above company is pumping In Med Pharmaceuti...

  • Avatar

    Medical Marijuana As A Potential Breast Cancer Treatment ... darkwebnews.com/drugs/medical-marijuana-potential-breast-c...

  • Avatar

    Just using google I ran into this: Zelda Therapeutics a medical cannabis biotechnology company has revealed medical mari...

  • Avatar

    If this is Mengels latest on the cure for breast cancer I can't figure it out either. Can't imagine something as newswo...

  • Avatar

    Does anyone know the ticker for the $1 stock that cures breast cancer?...

  • Avatar

    The C word terrifies us all. I'm sorry you had that experience. I think the cold reality is that all diseases affect ea...

  • Avatar

    Being a Breast Cancer Survivor,(early stage HR/PR Positive) I find this information concerning. Underwent a Lumpectomy, ...

  • SoGiAm

    #X-Cancer #TILs > Immune recognition of somatic mutations leading to complete durable regression in metastatic breast ca...

  • Avatar

    I am a firm believer in the value of the Primary Care Physician to the overall health care "system" (ironic laugh here)....

  • Avatar

    I believe that breast cancer treatment is going into Phase III. In the presentation they mention various milestone pay...

  • Avatar

    Took a position in $ONCYF today which is favorably viewed by KSS and Helen and Twitter. They have an upcoming presen...

  • Avatar

    Hi Porgie. I owned $SNDX for a while as well but sold out once I took another look at the phase 2 data for E2112 - HR+, ...

  • SoGiAm

    $OMCYF - Oncolytics Biotech(R) to Present REOLYSIN(R) at the 2018 Precision: Breast Cancer World R&D Summit 20180306 ...

  • Avatar

    Does anyone know the name of the company that has just successfully developed a cancer vaccine specifically for breast c...

  • SoGiAm

    $ONCYF np - 20180207; Oncolytics Biotech(R) to Host Conference Call Outlining the Treatment Paradigm of Metastatic Breas...

  • Avatar

    $CASC $SGEN “Seattle Genetics disappoints Puma bulls with Cascadian takeout” Date January 31, 2018 Why buy Pu...

  • Avatar

    ONCYF- NP as of yet. Data with Reolysin doubling the survival rate for metastatic breast cancer is off the chart good. ...

  • Avatar

    I missed this post earlier, but it is indeed Patriot One. The identity of the company was cracked the day the tease was...

  • Avatar

    Syndax Pharmaceuticals Is In For A Potentially Transformative 2018 Jan.25.18 | About: Syndax Pharmaceuticals, (SNDX) ...

  • Avatar

    $ONCS - long I still own ONCS. I'm very interested in hearing more of the bear argument. In truth, I'm low on portfo...

  • Avatar

    $liquidBiopsy $BIOC $AI $MachineLearning $NVDA “CancerSEEK: Blood Test That Detects Eight Common Cancers” Ale...

  • Avatar

    $ONCS, long. OncoSec Provides Encouraging Clinical Observations Related To Triple Negative Breast Cancer Study OncoS...

  • Avatar

    $HALO I reference the following extract from BioPharma Dive Sept. 14, 2017 titled Bristol, Roche tap Halozyme for tech p...

  • Avatar

    My wife was considering HRT 15 - 20 years ago but was scared off by the reported results of increased risk of breast can...

  • Avatar

    $RDUS NP J.P. Morgan note. “The presentation focused on the company’s commercial asset, Tymlos, which launc...

  • Avatar

    I also agree with Myron's comments. I was diagnosed with breast cancer in 2016 and sought out natural treatment. I refus...

  • Avatar

    $SNDX NP Syndax initiated with a Buy at B. Riley FBR B. Riley FBR analyst Madhu Kumar started Syndax Pharmaceutical...

  • Avatar

    $SNDX small position. Calendar says $SNDX Syndax Breast Cancer Ph3 PFS data "1H '18" So, if data is good sometime in...

  • Avatar

    $ONCS np; vs. $ONCYF np. Dr. KSS, both of these SanDiego based companies indicate their product turns cold tumors hot t...

  • Avatar

    $ONCS (long, ow) https://ir.oncosec.com/press-releases/detail/1931/oncosec-provides-2018-business-outlook OncoSec ...

  • Avatar

    $ ONCS LONG 03-Jan-2018:08:00:00, OncoSec Provides 2018 Business OutlookComplete stage 1 enrollment of PISCES/KEYNO...

  • Avatar

    kirzli, sndx-I share your concern, but I hope that entinostat will have better results with advanced hormone receptor po...

  • Avatar

    $FreeCME HER2-Positive Breast Cancer Since we discuss this often on here, this is a link for any healthcare profession...

  • DrKSSMDPhD

    I agree 100 percent. $SNDX shares have been sucked into the general vague biotech downdraft of recent weeks and saw some...

  • Avatar

    $SNDX This is a stock that has been puzzling me. I just keeps dropping. Their Phase 3 trial of Entinostat plus Aromac...

  • Avatar

    Thank you Doc for another excellent well reasoned and laid out article. Yes, I agree with you - I have at least one pati...

  • Avatar

    $BIOC, $SNDX long Thanks for the Syndax suggestion. I have been watching and unsure if I should nibble as well. I did...

  • Avatar

    $ONCS LONG Dr. Alain Algazi will present the updated data in an oral poster presentation (P524) at the Society for I...

  • Avatar

    $ONCS I am so impressed how this wonderful investing group works. Within a few hours after our lead scientist (DR. K...

  • DrKSSMDPhD

    First, bear in mind the space has much to prove. HDACi's haven't exactly blazed a path yet. I regard entinostat as being...

  • Avatar

    NP $ RDUS Radius Health announces that the FDA has granted Fast Track designation for elacestrant; (34.61) El...

  • Avatar

    Long $CLRB ll.com: Cellectar Biosciences receives additional Japanese patent for CLR 131, CLR 125 Cellectar Bioscie...

  • Avatar

    genetic tests for cancer are also available--free!--to survivers with a nasty family history of breast cancer, which cov...

  • Avatar

    $NVS It's as simple as a selfie and a hashtag on Twitter to raise money for metastatic breast cancer. Novartis don...

  • Avatar

    $SNDX Syndax - Subscriber Eemajin asked me an interesting question about $SNDX catalysts on the Gummie Catalyst Calendar...

  • Avatar

    $double post I'm happy to have read it twice Nocitons. While I'm here, I'd love to know if you, Doc, saw the Venb...

  • DrKSSMDPhD

    Hi....I tend to agree with you. For home gamers, CASC is the former OncoThyreon, and tucatinib inhibits the tyrosine kin...

  • Avatar

    Alley A Snickers would do it !! Look at all the other benefits of MetFormin. My wife as a breast cancer survivor got on ...

  • Avatar

    I met with MYGN a few years ago while the stock was still on the southbound express. Their super success story test (pr...

  • DrKSSMDPhD

    To round out linling's post, the PT of $29 is essentially a tripling of where shares of $SNDX sit now. I acquired my ove...

  • Avatar

    $SNDX Interesting the analyst didn't even mention the Phase 3 breast CA (which is somewhat behind schedule) ECOG-ACR...

  • DrKSSMDPhD

    PARPi olaparib boosts PFS in germline-BRCA mutational breast cancer. http://www.nejm.org/doi/full/10.1056/NEJMoa1706450...

  • Avatar

    Hi all - I just want to quickly share a personal story that shows a side of "big pharma" you most likely will never hea...

  • Avatar

    $Stem Cell Therapy - Novel Approach A stem cell-based method created by University of California, Irvine scientists c...

  • Avatar

    I will move this catalyst for $SNDX Breast Cancer program from October to December and indicate the two possible dates. ...

  • Avatar

    In any case Jab, $SNDX has several shots on goal with its 3 study Immuno-Oncology program and the FDA Breakthrough Ther...

  • Avatar

    The October Breast Cancer Entinostat HR event for Syndax is from the FDA's Biopharmcatalyst.com which has this with a No...

  • Avatar

    $SNDX- Yes this is 2 separate data readouts. SNDX's Entinostat has a breast cancer trial going on as well as an Imunoonc...

  • SoGiAm

    $BIOC long - Biocept Expands Commercial Offering of Clinically Actionable Biomarker Assays with Launch of Liquid Biopsy ...

  • Avatar

    Good listen on emerging data for breast cancer treatment in the future. http://noveltargets.com/category/season-3/ Che...

  • Avatar

    Wow, Doc, anything to help Inflammatory Breast Cancer would be fantastic news. My wife is six years on from her diagnos...

  • DrKSSMDPhD

    One wonders if ABX464 linked to the CLRB compound could have a role in inflammatory breast cancer, which is a dreaded ho...

  • DrKSSMDPhD

    A colleague, an Asian Indian female (and yes males do get breast cancer on occasion), lived 15 years with stage IV disea...

  • Avatar

    Thank you for your detailed explanation (I'd give two thumbs up if I could) of why you doubt efficacy in the human trial...

  • Avatar

    Wendy, She has been on meds for MS for over 20 years. These included betaseron, copaxone for many years, and tysabri f...

  • Avatar

    My best to you and your wife also. Last October my wife was diagnosed with triple negative breast cancer that was very u...

  • Avatar

    Astrazeneca's olaparib looks like the real deal for BRCA-mutated breast cancer. http://www.medscape.com/viewarticle/881...

  • Avatar

    $RDUS Long I am long on RDUS for its osteoporosis drug abaloparatide-SC. It's gotten FDA approval and is currently ...

  • Avatar

    Essiac is A cure for breast cancer nurse Rene M. Caisse ,was persecuted for helping cure paitionts with it.To get the or...

  • Avatar

    $RDUS Long : Hello Doc and fellow gummies, Since the tymlos approval and amgen safety issues, the stock has had extreme...

  • Avatar

    $IMMU A post from 2014 by Dr. KSS had somewhat positive things to say about Immunomedics. Their drug for triple negative...

  • Avatar

    $SNDX The enrollment and release of interim data for their Phase 3 in breast cancer is behind schedule. "Based on ...

  • Avatar

    I belong to a group of fans that reads and suggests changes to novels of Mark Dawson, a British writer of 007 type ficti...

  • Avatar

    Dr., I have a very basic question that perhaps you could spend a few minutes on during the call if you think it would be...

  • Avatar

    $RDUS np Thanks for the reminder. I've been in and out of RDUS since Glenn & Doc first brought it to our attention....

  • DrKSSMDPhD

    Interesting points, but it's not clear to me that PPAR gamma agonism would support elaboration of breast cancer. I'm not...

  • Avatar

    $Coffee Ralph: Thanks so much for a great reading list! I promptly launched into a search for practical ways to remov...

  • Avatar

    $VBLT Long VBL Therapeutics Presents Data on MOSPD2, a Novel Immuno-Oncology Target TEL AVIV, Israel, April 04,...

  • SoGiAm

    $VBLT long - VBL Therapeutics has added a news release to its Investor Relations website. http://ir.vblrx.com/phoenix.z...

  • Avatar

    $SNDX: Syndax announces 5 poster presentations at AACR17 (Washington, D.C., April 1-4) Key Entinostat Posters of ...

  • Avatar

    $TSRO: Jeff, congrats. You should thank yourself for a smart decision, not me. I am currently out of the shares, but...

  • Avatar

    $SNDX long This was one of the 12 Biotechs of Xmas. In Doc's original write up, I believe at that time they expected so...

  • Avatar

    $ no-ticker Researchers believe they have found the key to drug resistance in most common type of breast cancer htt...

  • We use cookies on this site to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies.

    More Info